Fig. 3From: De Novo Rational design of peptide-based covalent inhibitors via mapping of complementary binding site residues – technical protocol and case study on KRASG12C and BTK481CClassification of the 20 amino acid residues based on shared physiochemical features of the side chain groupBack to article page